Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Am J Cardiol. 2009 Dec 22;105(3):373. doi: 10.1016/j.amjcard.2009.09.041

Table 2. Cardiovascular Outcomes by Diabetic Status.

Variable Diabetes Mellitus
Yes
(n=285)
No
(n=702)
Heart Failure Death or Hospitalization for
Worsening HF
88 (30.9%) 133 (19.0%)
 Unadjusted HR (95% CI) 1.79 (1.37, 2.35, p<0.001) Reference
 Adjusted HR (95% CI) 1.68 (1.26, 2.25, p<0.001) Reference
Hospitalization for Worsening Heart Failure 81 (28.4%) 116 (16.5%)
 Unadjusted HR (95% CI) 1.88 (1.42, 2.50, p<0.001) Reference
 Adjusted HR (95% CI) 1.76 (1.30, 2.39, p<0.001) Reference
Heart Failure Death 21 (7.4 %) 43 (6.1 %)
 Unadjusted HR (95% CI) 1.26 (0.75, 2.12, p=0.39) Reference
 Adjusted HR (95% CI) 1.40 (0.78, 2.50, p=0.26) Reference
Total Mortality 81 (28.4 %) 150 (21.4%)
 Unadjusted HR (95% CI) 1.38 (1.06, 1.81, p=0.02) Reference
 Adjusted HR (95% CI) 1.48 (1.10, 1.99, p=0.009) Reference
Cardiovascular Mortality 58 (20.3%) 104 (14.8%)
 Unadjusted HR (95% CI) 1.43 (1.03, 1.97, p=0.03) Reference
 Adjusted HR (95% CI) 1.54 (1.08, 2.18, p=0.02) Reference
Cardiovascular Mortality or Hospitalization
for Worsening Heart Failure
116 (40.7%) 180 (25.6%)
 Unadjusted HR (95% CI) 1.76 (1.39, 2.22, p<0.001) Reference
 Adjusted HR (95% CI) 1.69 (1.32, 2.17, p<0.001) Reference

Model includes age, gender, left ventricular ejection fraction, cardiothoracic ratio, heart rate, diastolic blood pressure, brachial pulse pressure, number of signs or symptoms of heart failure, New York Heart Association classification, history of myocardial infarction, ischemic heart failure etiology, previous digoxin use, non-potassium sparing diuretic use, glomerular filtration rate and body-mass index.